D-0636-2017 Class III Terminated
FDA drug recall D-0636-2017 was initiated by G & W Laboratories, Inc. on Mar 20, 2017 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert. The recall status is terminated (terminated Feb 14, 2018). Affected quantity: 230,700 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 12, 2017
- Initiation Date
- Mar 20, 2017
- Termination Date
- Feb 14, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 230,700 tubes
Product description
Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15), b) 30 g tubes (NDC 0713-0638-31), and c) 90 g tubes (NDC 0713-0638-18), Rx only, Manufactured by: G&W Laboratories, Inc., South Plainfeld, NJ 07080.
Reason for recall
Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.
Distribution pattern
Nationwide in the USA and Puerto Rico
Code information
Lot #: a) 63800090, Exp 04/17; 63800095, Exp 11/17; 1000573, Exp 02/18; 1002560, Exp 06/18; b) 63800090, Exp 04/17; 63800092, Exp 07/17; 63800093, Exp 08/17; 63800095, Exp 11/17; 1000574, Exp 02/18; 1001772, Exp 05/18; c) 63800089, Exp 03/17; 63800091, Exp 07/17; 63800094, Exp 08/17; 1000842, Exp 01/18; 1000966, Exp 03/18; 1001771, Exp 05/18; 1002562, Exp 06/18.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0636-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026